Literature DB >> 8406820

Cation flux studies of the lesion induced in human erythrocyte membranes by the thermostable direct hemolysin of Vibrio parahaemolyticus.

J S Huntley1, A C Hall, V Sathyamoorthy, R H Hall.   

Abstract

Vibrio parahaemolyticus, an important agent of seafood-borne gastroenteritis, expresses several putative virulence factors that could account for the disease symptoms of infected humans, namely, diarrhea, nausea, and abdominal cramps. The pathogenicity of V. parahaemolyticus correlates well with the Kanagawa phenomenon (the hemolytic ability of strains grown on Wagatsuma blood agar), implicating the thermostable direct hemolysin (TDH) as the predominant toxin responsible for pathogenicity. TDH-induced hemolysis could be inhibited by the addition of the osmolyte sorbitol to the extracellular solution, supporting the hypothesis that hemolysis occurs through colloid osmosis secondary to an increase in the cation permeability of the membrane. The effect of TDH on cation permeability was investigated by measuring K+ (congener, 86Rb+) influx into human erythrocytes in which the endogenous cation transporters had been blocked (by use of ouabain, bumetanide, and nitrendipine). TDH increased K+ influx into these cells; this increase was rapid in onset and constant in magnitude, suggesting a direct action by TDH on the membrane. The kinetics of leak generation were examined; the relationship between counts accumulated and hematocrit indicated that the TDH-induced lesion is multihit in nature. TDH-induced K+ influx was sensitive to Zn2+. Time courses of hemolysis in isosmotic solutions of monovalent cation chlorides were used to obtain the selectivity series for the TDH-induced leak: Cs+ > Li+ > K+ > Rb+ > Na+. Both the Zn2+ sensitivity and this selectivity series were obtained for crude culture supernatants, suggesting that TDH is the predominant leak-inducing agent. Thus, we have identified several features of the TDH-induced leak likely to be important in the diarrhetic action of V. parahaemolyticus in the human intestine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406820      PMCID: PMC281161          DOI: 10.1128/iai.61.10.4326-4332.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Interaction of thermostable direct hemolysin of Vibrio parahaemolyticus with human erythrocytes.

Authors:  J Sakurai; M A Bahavar; Y Jinguji; T Miwatani
Journal:  Biken J       Date:  1975-12

2.  The thermostable direct hemolysin of Vibrio parahaemolyticus is a pore-forming toxin.

Authors:  T Honda; Y Ni; T Miwatani; T Adachi; J Kim
Journal:  Can J Microbiol       Date:  1992-11       Impact factor: 2.419

3.  Cytotoxic effect of the thermostable direct hemolysin produced by Vibrio parahaemolyticus on FL cells.

Authors:  J Sakurai; T Honda; Y Jinguji; M Arita; T Miwatani
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  Inactivation of the biological activities of the thermostable direct hemolysin of Vibrio parahaemolyticus by ganglioside Gt1.

Authors:  Y Takeda; T Takeda; T Honda; T Miwatani
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

Review 5.  Thermostable direct hemolysin of Vibrio parahaemolyticus.

Authors:  Y Takeda
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

6.  A method for estimating free Ca within human red blood cells, with an application to the study of their Ca-dependent K permeability.

Authors:  T J Simons
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

Review 7.  Diseases of humans (other than cholera) caused by vibrios.

Authors:  P A Blake; R E Weaver; D G Hollis
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

8.  Simplified purification and biophysicochemical characteristics of Kanagawa phenomenon-associated hemolysin of Vibrio parahaemolyticus.

Authors:  Y Miyamoto; Y Obara; T Nikkawa; S Yamai; T Kato; Y Yamada; M Ohashi
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

Review 9.  Vibrio parahaemolyticus and related halophilic Vibrios.

Authors:  S W Joseph; R R Colwell; J B Kaper
Journal:  Crit Rev Microbiol       Date:  1982       Impact factor: 7.624

10.  Production and properties of heat-stable extracellular hemolysin from Pseudomonas aeruginosa.

Authors:  M K Johnson; D Boese-Marrazzo
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more
  6 in total

1.  Vibrio parahaemolyticus thermostable direct hemolysin modulates cytoskeletal organization and calcium homeostasis in intestinal cultured cells.

Authors:  A Fabbri; L Falzano; C Frank; G Donelli; P Matarrese; F Raimondi; A Fasano; C Fiorentini
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

Review 2.  Thermostable direct hemolysin gene of Vibrio parahaemolyticus: a virulence gene acquired by a marine bacterium.

Authors:  M Nishibuchi; J B Kaper
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

3.  A mutant toxin of Vibrio parahaemolyticus thermostable direct hemolysin which has lost hemolytic activity but retains ability to bind to erythrocytes.

Authors:  G Q Tang; T Iida; K Yamamoto; T Honda
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

4.  Development and evaluation of a rapid, simple, and sensitive immunochromatographic assay to detect thermostable direct hemolysin produced by Vibrio parahaemolyticus in enrichment cultures of stool specimens.

Authors:  Kentaro Kawatsu; Masanori Ishibashi; Teizo Tsukamoto
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 5.  Fitness factors in vibrios: a mini-review.

Authors:  Crystal N Johnson
Journal:  Microb Ecol       Date:  2013-01-10       Impact factor: 4.552

6.  Cell-free production of pore forming toxins: Functional analysis of thermostable direct hemolysin from Vibrio parahaemolyticus.

Authors:  Srujan Kumar Dondapati; Doreen A Wüstenhagen; Eckhard Strauch; Stefan Kubick
Journal:  Eng Life Sci       Date:  2017-12-11       Impact factor: 2.678

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.